Literature DB >> 6326145

Organization of collagen types I and V in the embryonic chicken cornea: monoclonal antibody studies.

J M Fitch, J Gross, R Mayne, B Johnson-Wint, T F Linsenmayer.   

Abstract

To determine whether type V collagen is antigenically masked in situ by its fibrillar organization, two different methods were used to perturb selectively the structure of collagen fibrils in sections of embryonic chicken corneas. The experimentally modified tissues were probed by immunohistochemical procedures with monoclonal antibodies against types V and I. A lathyritic agent was used to block crosslinking of newly synthesized collagen. This results in reversible temperature-sensitive alterations in fibrillar packing, such that freshly formed collagen fibrils retain their aggregated state at 37 degrees C but become dissociated upon cooling. Type V-specific immunofluorescence remained masked at 37 degrees C but was revealed at 0 degree C. The effect of temperature was partially reversible, indicating that type V collagen is normally unavailable for antibody binding because of its fibrillar arrangement. In sections of normal corneas, treatment with corneal collagenase, which degrades type I collagen, but not type V, also unmasked the latter. This implicates type I collagen as the masking agent. We propose that collagen types I and V are incorporated together in heterotypic fibrils.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6326145      PMCID: PMC345156          DOI: 10.1073/pnas.81.9.2791

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  14 in total

Review 1.  Cross-linking of collagen.

Authors:  M L Tanzer
Journal:  Science       Date:  1973-05-11       Impact factor: 47.728

2.  Quantitative analysis of the collagens in the bovine cornea.

Authors:  P F Davison; B S Hong; D J Cannon
Journal:  Exp Eye Res       Date:  1979-08       Impact factor: 3.467

3.  A quantitative collagen film collagenase assay for large numbers of samples.

Authors:  B Johnson-Wint
Journal:  Anal Biochem       Date:  1980-05-01       Impact factor: 3.365

4.  Synthesis of type V collagen by chick corneal fibroblasts in vivo and in vitro.

Authors:  A Pöschl; K von der Mark
Journal:  FEBS Lett       Date:  1980-06-16       Impact factor: 4.124

5.  Collagen heterogeneity in normal rabbit cornea. I. Isolation and biochemical characterization of the genetically-distinct collagens.

Authors:  C Welsh; S Gay; R K Rhodes; R Pfister; E J Miller
Journal:  Biochim Biophys Acta       Date:  1980-09-23

6.  Immunohistochemical localization of collagen types I and II in the developing chick cornea and tibia by electron microscopy.

Authors:  M J Hendrix; E D Hay; K von der Mark; T F Linsenmayer
Journal:  Invest Ophthalmol Vis Sci       Date:  1982-03       Impact factor: 4.799

7.  Morphologic evidence for collagen changes in chick embryos treated with beta-aminopropionitrile.

Authors:  A VAN DEN HOOFF; C I LEVENE; J GROSS
Journal:  J Exp Med       Date:  1959-12-01       Impact factor: 14.307

8.  Monoclonal antibodies against chicken type V collagen: production, specificity, and use for immunocytochemical localization in embryonic cornea and other organs.

Authors:  T F Linsenmayer; J M Fitch; T M Schmid; N B Zak; E Gibney; R D Sanderson; R Mayne
Journal:  J Cell Biol       Date:  1983-01       Impact factor: 10.539

9.  Alterations in state of molecular aggregation of collagen induced in chick embryos by beta-aminopropionitrile (lathyrus factor).

Authors:  C I LEVENE; J GROSS
Journal:  J Exp Med       Date:  1959-11-01       Impact factor: 14.307

10.  Domain and basement membrane specificity of a monoclonal antibody against chicken type IV collagen.

Authors:  J M Fitch; E Gibney; R D Sanderson; R Mayne; T F Linsenmayer
Journal:  J Cell Biol       Date:  1982-11       Impact factor: 10.539

View more
  13 in total

Review 1.  The avian muscle spindle.

Authors:  A Maier
Journal:  Anat Embryol (Berl)       Date:  1992

2.  Development of a functional skin matrix requires deposition of collagen V heterotrimers.

Authors:  Hélène Chanut-Delalande; Christelle Bonod-Bidaud; Sylvain Cogne; Marilyne Malbouyres; Francesco Ramirez; Agnès Fichard; Florence Ruggiero
Journal:  Mol Cell Biol       Date:  2004-07       Impact factor: 4.272

3.  The pro alpha 2(V) collagen gene is evolutionarily related to the major fibrillar-forming collagens.

Authors:  D Weil; M Bernard; S Gargano; F Ramirez
Journal:  Nucleic Acids Res       Date:  1987-01-12       Impact factor: 16.971

Review 4.  Structure and function of the skeletal muscle extracellular matrix.

Authors:  Allison R Gillies; Richard L Lieber
Journal:  Muscle Nerve       Date:  2011-09       Impact factor: 3.217

5.  An immunohistochemical study of human endometrial extracellular matrix during the menstrual cycle and first trimester of pregnancy.

Authors:  J D Aplin; A K Charlton; S Ayad
Journal:  Cell Tissue Res       Date:  1988-07       Impact factor: 5.249

6.  Ultrastructure of the corneal stroma: a comparative study.

Authors:  K M Meek; D W Leonard
Journal:  Biophys J       Date:  1993-01       Impact factor: 4.033

Review 7.  Tendon Extracellular Matrix Assembly, Maintenance and Dysregulation Throughout Life.

Authors:  Seyed Mohammad Siadat; Danae E Zamboulis; Chavaunne T Thorpe; Jeffrey W Ruberti; Brianne K Connizzo
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

8.  The spatial organization of Descemet's membrane-associated type IV collagen in the avian cornea.

Authors:  J M Fitch; D E Birk; C Linsenmayer; T F Linsenmayer
Journal:  J Cell Biol       Date:  1990-04       Impact factor: 10.539

9.  Type III collagen can be present on banded collagen fibrils regardless of fibril diameter.

Authors:  D R Keene; L Y Sakai; H P Bächinger; R E Burgeson
Journal:  J Cell Biol       Date:  1987-11       Impact factor: 10.539

10.  Embryonic avian cornea contains layers of collagen with greater than average stability.

Authors:  T F Linsenmayer; E Gibney; J M Fitch
Journal:  J Cell Biol       Date:  1986-10       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.